Page last updated: 2024-10-26

diphenyleneiodonium and Acquired-Immune Deficiency Syndrome Dementia Complex

diphenyleneiodonium has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, HY1
Ju, SM1
Seo, WY1
Goh, AR1
Lee, JK1
Bae, YS1
Choi, SY1
Park, J1

Other Studies

1 other study available for diphenyleneiodonium and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Nox2-based NADPH oxidase mediates HIV-1 Tat-induced up-regulation of VCAM-1/ICAM-1 and subsequent monocyte adhesion in human astrocytes.
    Free radical biology & medicine, 2011, Mar-01, Volume: 50, Issue:5

    Topics: AIDS Dementia Complex; Astrocytes; Cell Adhesion; Cell Line, Tumor; Gene Knockdown Techniques; HIV-1

2011